2018/06/26 by Sydney T Osland, Thomas Steeves, Tamara Pringsheim · 1 citation
Medicine · Psychology · #Attention Deficit Hyperactivity Disorder #Obsessive-Compulsive Spectrum Disorders #Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
paper · pdf · doi:10.1002/14651858.cd007990.pub3
openalex publication_date 2018/06/26 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01
This is an update of the original Cochrane Review published in Issue 4, 2011.Attention deficit hyperactivity disorder (ADHD) is the most prevalent of the comorbid psychiatric disorders that complicate tic disorders. Medications commonly used to treat ADHD symptoms include stimulants such as methylphenidate and amphetamine; non-stimulants, such as atomoxetine; tricyclic antidepressants; and alpha agonists. Alpha agonists are also used as a treatment for tics. Due to the impact of ADHD symptoms on the child with tic disorder, treatment of ADHD is often of greater priority than the medical management of tics. However, for many decades, clinicians have been reluctant to use stimulants to treat children with ADHD and tics for fear of worsening their tics. OBJECTIVES: To assess the effects of pharmacological treatments for ADHD in children with comorbid tic disorders on symptoms of ADHD and tics.